Citation Impact
Citing Papers
Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β
1997 Standout
Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial Carcinoma
2008
Seven Years’ Experience with 5-Aminolevulinic Acid in Detection of Transitional Cell Carcinoma of the Bladder
2007
Functional diversity of helper T lymphocytes
1996 StandoutNature
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Optimal Management of the T1G3 Bladder Cancer
2005
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Testicular cancer
2018
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Cancer burden in the year 2000. The global picture
2001 Standout
Estrogen receptors and human disease
2006 Standout
Androgen receptor expression of proliferating basal and luminal cells in adult murine ventral prostate
1999
Photodynamic Therapy
1998 Standout
OCT4 Staining in Testicular Tumors
2004
Trends in incidence of testicular cancer and prostate cancer in Denmark
2001
Clinical Outcome in a Contemporary Series of Restaged Patients with Clinical T1 Bladder Cancer
2009
ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival
2004
Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue
1992
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
2007 Standout
The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology
2008
Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies
2002
Current views on the pathogenesis of testicular germ cell tumours and perspectives for future research: Highlights of the 5th Copenhagen Workshop on Carcinoma in situ and Cancer of the Testis
2003
Developmental estrogenization and prostatic neoplasia
1994
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
A Second-Look TUR in T1 Transitional Cell Carcinoma: Why?
2004
Activated leukocyte cell adhesion molecule expression predicts lymph node metastasis in oral squamous cell carcinoma
2010
Gonadal function in men with testicular cancer: Biological and clinical aspects
1998
Comparative Studies of the Estrogen Receptors β and α and the Androgen Receptor in Normal Human Prostate Glands, Dysplasia, and in Primary and Metastatic Carcinoma
2001
Transurethral Resection and Surveillance of Bladder Cancer Supported by 5-Aminolevulinic Acid-Induced Fluorescence Endoscopy
1999
Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis
2012
Colorectal cancer
2013 Standout
Salivary-type neoplasms of the breast and lung
2003
The Value of a Second Transurethral Resection in Evaluating Patients with Bladder Tumours
2003
The development of androgen-independent prostate cancer
2001 Standout
Quality control in transurethral resection of bladder tumours
2008
The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer
2007
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Induction of leydig cell adenomas by ammonium perfluorooctanoate: A possible endocrine-related mechanism
1992
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
Prise en charge de la pièce de prostatectomie radicale. Résultats de la conférence de consensus de la Société internationale d’uropathologie (ISUP)
2013
Image-guided cancer surgery using near-infrared fluorescence
2013 Standout
Testicular germ-cell tumours in a broader perspective
2005 Standout
Second Malignancies following Pure Seminoma
2000
Overexpression of Aromatase Leads to Development of Testicular Leydig Cell Tumors
2000
Chromosomes, genes, and development of testicular germ cell tumors
2004
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Senkung des Rezidivrisikos oberfl�chlicher Harnblasenkarzinome mittels 5-Aminol�vulins�ure-induzierter Fluoreszenzdiagnostik
2003
Mechanisms of Extrahepatic Tumor Induction by Peroxisome Proliferators in Male CD Rats
2001
Clinical Results of the Transurethral Resection and Evaluation of Superficial Bladder Carcinomas by Means of Fluorescence Diagnosis after Intravesical Instillation of 5-Aminolevulinic Acid
1999
The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary
2003
EAU Guidelines on Prostate Cancer
2007 Standout
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Estrogen Receptors in Human Nontarget Tissues: Biological and Clinical Implications*
1995
Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens
2012
The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary Bladder
1998 Standout
Regional differences in the prostate of the neonatally estrogenized mouse
1991
Second Transurethral Resection after Ta High-Grade Bladder Tumor: A 4.5-Year Period at a Single University Center
2013
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Consensus Statement on Management of Intersex Disorders
2006 Standout
Microenvironmental regulation of metastasis
2008 Standout
Ki‐67 labeling in postmitotic cells defines different Ki‐67 pathways within the 2c compartment
1991
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 StandoutNature
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
The Ki-67 protein: From the known and the unknown
2000 Standout
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
2015 Standout
Clonal evolution in cancer
2012 StandoutNature
Estrogen Receptor Expression in Prostate Cancer and Premalignant Prostatic Lesions
1999
Proteasome Inhibitors with Photocontrolled Activity
2014 StandoutNobel
Bladder cancer: Epidemiology, staging and grading, and diagnosis
2005 Standout
CarcinomaIn situ of the testis: Review of biological and clinical features
1999
Clinically Relevant Reduction in Risk of Recurrence of Superficial Bladder Cancer Using 5-Aminolevulinic Acid-Induced Fluorescence Diagnosis: 8-Year Results of Prospective Randomized Study
2007
Renal cell carcinoma
2017 Standout
Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data
2013
Cystectomy in Patients with High Risk Superficial Bladder Tumors Who Fail Intravesical BCG Therapy:
2005
Transurethral Resection of Non–Muscle-Invasive Bladder Transitional Cell Cancers With or Without 5-Aminolevulinic Acid Under Visible and Fluorescent Light: Results of a Prospective, Randomised, Multicentre Study
2009
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Lymphatic Vessel Activation in Cancer
2008
Global cancer statistics in the year 2000
2001 Standout
Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity
2010 Standout
Fluorescence Detection of Bladder Tumors with 5-Amino-Levulinic Acid
1999
5-aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumors
1999
ALTERATION OF SERTOLI CELL DIFFERENTIATION IN THE PRESENCE OF CARCINOMA IN SITU IN HUMAN TESTES
1998
Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase.
2002 Standout
Prognostic Significance of Tumor Volume in Radical Prostatectomy and Needle Biopsy Specimens
2011
Diagnosis of Prostatic Carcinoma: The Yield of Serum Prostate Specific Antigen, Digital Rectal Examination and Transrectal Ultrasonography
1994
SECOND RESECTION AND PROGNOSIS OF PRIMARY HIGH RISK SUPERFICIAL BLADDER CANCER: IS CYSTECTOMY OFTEN TOO EARLY?
2001
RESTAGING TRANSURETHRAL RESECTION OF HIGH RISK SUPERFICIAL BLADDER CANCER IMPROVES THE INITIAL RESPONSE TO BACILLUS CALMETTE-GUERIN THERAPY
2005
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
2013
LONG-TERM BENEFIT OF 5-AMINOLEVULINIC ACID FLUORESCENCE ASSISTED TRANSURETHRAL RESECTION OF SUPERFICIAL BLADDER CANCER: 5-YEAR RESULTS OF A PROSPECTIVE RANDOMIZED STUDY
2005
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
The Effect of Repeat Transurethral Resection on Recurrence and Progression Rates in Patients With T1 Tumors of the Bladder Who Received Intravesical Mitomycin: A Prospective, Randomized Clinical Trial
2006
Effect of Routine Repeat Transurethral Resection for Superficial Bladder Cancer: A Long-term Observational Study
2003
IMPROVED DETECTION AND TREATMENT OF BLADDER CANCER USING HEXAMINOLEVULINATE IMAGING: A PROSPECTIVE, PHASE III MULTICENTER STUDY
2005
Transurethral Resection For Bladder Cancer Using 5-Aminolevulinic Acid Induced Fluorescence Endoscopy Versus White Light Endoscopy
2002
Bladder Cancer
2020 Standout
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Polyfluorinated Compounds: Past, Present, and Future
2011 Standout
Bilateral Testicular Microlithiasis Predicts the Presence of the Precursor of Testicular Germ Cell Tumors in Subfertile Men
2004
Mechanisms of Estrogen Action
2001 Standout
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research
2020 Standout
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
1993
The diagnosis, management, treatment and costs of prostate cancer in England and Wales.
1997
Initial Tumor Stage and Grade as a Predictive Factor for Recurrence in Patients With Stage T1 Grade 3 Bladder Cancer
2004
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Clinically Relevant Improvement of Recurrence-free Survival with 5-Aminolevulinic Acid Induced Fluorescence Diagnosis in Patients with Superficial Bladder Tumors
2002
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Increased Risk of Carcinoma In Situ In Patients With Testicular Germ Cell Cancer With Ultrasonic Microlithiasis In the Contralateral Testicle
2003
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
FLUORESCENCE ENDOSCOPY WITH 5-AMINOLEVULINIC ACID REDUCES EARLY RECURRENCE RATE IN SUPERFICIAL BLADDER CANCER
2001
Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors.
2003
Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.
1991
Hoxb13is required for normal differentiation and secretory function of the ventral prostate
2003 StandoutNobel
Clinically Relevant Improvement of Recurrence-free Survival with 5-Aminolevulinic Acid Induced Fluorescence Diagnosis in Patients with Superficial Bladder Tumors
2002
The Importance of the Depth of Invasion in Stage T1 Bladder Carcinoma: A Prospective Cohort Study
1997
THE VALUE OF A SECOND TRANSURETHRAL RESECTION IN EVALUATING PATIENTS WITH BLADDER TUMORS
1999
Carcinoma in situ in the Testis
2000
CD30 and type 2 T helper (Th2) responses
1995
Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects: Opinion
2001 Standout
THE CURRENT STATUS OF BLADDER PRESERVATION IN THE TREATMENT OF MUSCLE INVASIVE BLADDER CANCER
2000
Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin Fluorescence
1996
Works of V. Loy being referenced
Diagnosis and management of testicular intraepithelial neoplasia (carcinoma in situ) – surgical aspects
2003
Prevalence of Bilateral TesticularGerm Cell Tumors andEarly Detection by TesticularIntraepithelial Neoplasia
1993
Epidermoid cyst of the testis: a review of clinical and histogenetic considerations
1994
Testicular microlithiasis: Case report and discussion of management under special consideration of testicular germ cell tumours
1996
Prevalence of Bilateral Testicular Germ Cell Tumours and Early Detection Based on Contralateral Testicular Intra‐epithelial Neoplasia
1993
Seminoma Testis and Concomitant Ipsilateral Renal Cell Carcinoma
1988
Low-dose radiation therapy for testicular intraepithelial neoplasia
1993
Prognostic impact of lymphovascular invasion in radical prostatectomy specimens
2006
ALCAM/CD166 is up‐regulated in low‐grade prostate cancer and progressively lost in high‐grade lesions
2002
Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms.
1996
False-Negative Biopsies for the Diagnosis of Testicular Intraepithelial Neoplasia (TIN)—An Update
2003
Incidence and distribution of carcinoma in situ in testes removed for germ cell tumour: possible inadequacy of random testicular biopsy in detecting the condition
1990
Prevalence of Contralateral TesticularIntraepithelial Neoplasia(Carcinoma in situ) in Patients withTesticular Germ Cell Tumour
1993
Investigations of the estrogen (ER-ICA-test) and the progesterone receptor in the prostate and prostatic carcinoma on immunohistochemical basis
1988
Intratesticular Effects ofCisplatin-Based Chemotherapy
1995
Optimised surgery (so-called TME surgery) and high-resolution MRI in the planning of treatment of rectal carcinoma
2007
The value of the biopsy of the contralateral testis in patients with testicular germ cell cancer: The recent German experience
1998
Visual estimation of the tumor volume in prostate cancer: a useful means for predicting biochemical-free survival after radical prostatectomy?
2006
Die testikuläre intraepitheliale Neoplasie (TIN)
1998
Prostate Cancer in Nonurological Patients with Normal Prostates on Digital Rectal Examination
1992
CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule.
1995
Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group
2008
Residual Tumor Discovered in Routine Second Transurethral Resection in Patients with Stage T1 Transitional Cell Carcinoma of the Bladder
1991
FALSE-NEGATIVE BIOPSIES FOR TESTICULAR INTRAEPITHELIAL NEOPLASIA
1999
Risk Factors for Relapse in Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: Results of the German Testicular Cancer Study Group Trial
2003
Immunohistological determination of oestrogen receptor, progesterone receptor, and intermediate filaments in Leydig cell tumours, Leydig cell hyperplasia, and normal Leydig cells of the human testis
1989
Paternity in a patient with testicular seminoma and contralateral testicular intraepithelial neoplasia
1993
Characterisation of adenoid cystic carcinoma of the breast by immunohistology.
1989
Immunohistological determination of proliferative activity in seminomas.
1988